The orthopedic robotics market continues to gain momentum and validation with increasing competition and development milestones being met by key companies in the space.
Robotics continued to take center stage in the computer-assisted orthopedic surgery space in Q319. The orthopedic robotics market continues to gain momentum and validation with increasing competition and development milestones being met by key companies in the space. Zimmer Biomet has come out of the gate with strong demand for its ROSA total knee platform. However, the increasing competition is likely not a negative for market leader Stryker, given the early stage of adoption of orthopedic robotics. Smith & Nephew continued to make headway with its NAVIO platform and the development of a next-gen system, and DePuy Synthes remains on track for FDA submission in 2021. The competitive landscape continues to become more crowded with...
Among the many topics covered in the complete, comprehensive Q319 CAS Ortho Market Recap* are:
- Complete Q319 CAS Ortho Market recap
- Stryker Continues to Gain
- Zimmer Biomet Shifts Focus
- Smith & Nephew's Robotic Strategy
- DePuy Synthes Enabling Technologies
- Globus Differentiates Itself
-
Product Launches, Regulatory Milestones and Other Highlights
, +10.6% YoY, Smith & Nephew reported double-digit growth for its NAVIO robotics platform, Zimmer Biomet’s +4.9% Knee growth in Q319 was the best for the Company in the last three years, and DePuy Synthes management noted that its R&D investment in the quarter was 12.5%, up by +20 basis points over the previous quarter in 2018, driven by investments in robotics, digital and key growth platforms. Not to be left out, companies with other enabling technologies reached significant milestones in the quarter as well, including...*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
